tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - Антинеопластични средства - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
remiffentanil hospira 1 mg powder for concentrate for injection/infusion
hospira uk ltd. - Ремифентанил - 1 mg powder for concentrate for injection/infusion
remiffentanil hospira 2 mg powder for concentrate for injection/infusion
hospira uk ltd. - Ремифентанил - 2 mg powder for concentrate for injection/infusion
remiffentanil hospira 5 mg powder for concentrate for injection/infusion
hospira uk ltd. - Ремифентанил - 5 mg powder for concentrate for injection/infusion
fentoril 50 micrograms/ml solution for injection
СОФАРМА АД - Фентанил - 50 micrograms/ml solution for injection
victanyl 25 micrograms/h transdermal patch
actavis group ptc ehf - Фентанил - 25 micrograms/h transdermal patch
victanyl 50 micrograms/h transdermal patch
actavis group ptc ehf - Фентанил - 50 micrograms/h transdermal patch
victanyl 75 micrograms/h transdermal patch
actavis group ptc ehf - Фентанил - 75 micrograms/h transdermal patch
victanyl 100 micrograms/h transdermal patch
actavis group ptc ehf - Фентанил - 100 micrograms/h transdermal patch
fentanyl-richter 50 micrograms/ml solution for injection
gedeon richter plc. - Фентанил - 50 micrograms/ml solution for injection